Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-312024-04-01falseNo description of principal activity22truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 10050334 2024-04-01 2025-03-31 10050334 2023-04-01 2024-03-31 10050334 2025-03-31 10050334 2024-03-31 10050334 c:Director1 2024-04-01 2025-03-31 10050334 d:OfficeEquipment 2024-04-01 2025-03-31 10050334 d:OfficeEquipment 2025-03-31 10050334 d:OfficeEquipment 2024-03-31 10050334 d:OfficeEquipment d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 10050334 d:CurrentFinancialInstruments 2025-03-31 10050334 d:CurrentFinancialInstruments 2024-03-31 10050334 d:Non-currentFinancialInstruments 2025-03-31 10050334 d:Non-currentFinancialInstruments 2024-03-31 10050334 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 10050334 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 10050334 d:Non-currentFinancialInstruments d:AfterOneYear 2025-03-31 10050334 d:Non-currentFinancialInstruments d:AfterOneYear 2024-03-31 10050334 d:Non-currentFinancialInstruments d:MoreThanFiveYears 2025-03-31 10050334 d:Non-currentFinancialInstruments d:MoreThanFiveYears 2024-03-31 10050334 d:ShareCapital 2025-03-31 10050334 d:ShareCapital 2024-03-31 10050334 d:RetainedEarningsAccumulatedLosses 2025-03-31 10050334 d:RetainedEarningsAccumulatedLosses 2024-03-31 10050334 c:OrdinaryShareClass1 2024-04-01 2025-03-31 10050334 c:OrdinaryShareClass1 2025-03-31 10050334 c:OrdinaryShareClass1 2024-03-31 10050334 c:FRS102 2024-04-01 2025-03-31 10050334 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 10050334 c:FullAccounts 2024-04-01 2025-03-31 10050334 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10050334 2 2024-04-01 2025-03-31 10050334 e:PoundSterling 2024-04-01 2025-03-31 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 10050334









DOC HEARTS LTD







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2025

 
DOC HEARTS LTD
 

CONTENTS



Page
Statement of financial position
 
1
Notes to the financial statements
 
2 - 6


 
DOC HEARTS LTD
REGISTERED NUMBER: 10050334

STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2025

2025
2024
Note
£
£

Fixed assets
  

Intangible assets
  
2,400
-

Tangible assets
 4 
2,447
3,678

Current assets
  

Debtors: amounts falling due within one year
 5 
389,189
262,524

Cash at bank and in hand
  
108,086
497,052

Curent Liabilities
  
497,275
759,576

Creditors: amounts falling due within one year
 6 
(306,141)
(680,115)

Net current assets
  
191,134
79,461

Total assets less current liabilities
  
195,981
83,139

Creditors: amounts falling due after more than one year
 7 
(1,667)
(11,667)

Net assets
  
194,314
71,472


Capital and reserves
  

Called up share capital 
 9 
1,000
1,000

Profit and loss account
  
193,314
70,472

  
194,314
71,472


The director considers that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 23 December 2025.

P Mundy-Castle
Director

The notes on pages 2 to 6 form part of these financial statements.

Page 1

 
DOC HEARTS LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.


General information

Doc Hearts Ltd is a private company limited by shares and registered in England and Wales. The address of its registered office is Suite 6, 2 Station Court, Townsmead Road, london, SW6 2PY.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Revenue comprises of revenues receivable by the company during the financial reporting period in respect of the supply of various media production services.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
25%
straight line method

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Page 2

 
DOC HEARTS LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.6

Debtors

Short term debtors are measured at transaction price, less any impairment.

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours.

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.9

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2024 - 2).

Page 3

 
DOC HEARTS LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

4.


Tangible fixed assets





Office equipment

£



Cost


At 1 April 2024
7,553



At 31 March 2025

7,553



Depreciation


At 1 April 2024
3,875


Charge for the year on owned assets
1,231



At 31 March 2025

5,106



Net book value



At 31 March 2025
2,447



At 31 March 2024
3,678


5.


Debtors

2025
2024
£
£


Trade debtors
251,589
579

Other debtors
122,013
193,714

Prepayments and accrued income
7,177
68,231

Tax recoverable
8,410
-

389,189
262,524


Page 4

 
DOC HEARTS LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

6.


Creditors: Amounts falling due within one year

2025
2024
£
£

Bank loan
10,000
10,000

Trade creditors
53,429
41,686

Other taxation and social security
63,065
7,071

Other creditors
57,855
610,820

Accruals
121,792
10,538

306,141
680,115



7.


Creditors: Amounts falling due after more than one year

2025
2024
£
£

Bank loan
1,667
11,667


The following liabilities were secured:

2025
2024
£
£



Bank Loan
11,667
21,667

11,667
21,667

Details of security provided:

The bank loan of £11,667 (2024: £21,667) is secured by a fixed charge over the company’s equipment.

Page 5

 
DOC HEARTS LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

8.


Loans


Analysis of the maturity of loans is given below:


2025
2024
£
£

Amounts falling due within one year

Bank loan
10,000
10,000

Amounts falling due after more than 5 years

Bank loan
1,667
11,667

11,667
21,667



9.


Share capital

2025
2024
£
£
Allotted, called up and fully paid



1,000 (2024 - 1,000) Ordinary shares shares of £1.00 each
1,000
1,000



10.


Related party transactions

At the reporting date, the company owed £984 (2024: £2,055) to its director and the company was owed £14,631 (2024:£551,589 owed to) from Power and Protest Ltd, company controlled by the director.


11.


Controlling party

The company is controlled by its director who is a majority shareholder of the company.

 
Page 6